Cognitive sequelae of intravenous amphetamine self-administration in rats: Evidence for selective effects on attentional performance

Neuropsychopharmacology

Volumn 30, Issue 3, 2005, Pages 525-537

  Dalley, Jeffrey W ^a   Theobald, David E H ^a   Berry, David ^b   Milstein, Jean A ^a   Lääne, Kristjan ^a   Everitt, Barry J ^a   Robbins, Trevor W ^a  

^a UK   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

5 choice serial reaction time task; Drug addiction; Executive function; Impulsivity; Psychomotor stimulants; Visual attention

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT;

ACCURACY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; DRUG USE; DRUG WITHDRAWAL; ERROR; FIVE CHOICE SERIAL REACTION TIME TASK; FOOD INTAKE; IMPULSIVENESS; INTRAVENOUS DRUG ABUSE; MALE; NONHUMAN; PERSEVERATION; PRIORITY JOURNAL; RAT; RELAPSE; TASK PERFORMANCE; TRAINING;

AMPHETAMINE; ANIMALS; ATTENTION; CHOICE BEHAVIOR; COGNITION; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, INBRED STRAINS; REACTION TIME; SELF ADMINISTRATION;

EID: 13944269577     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300590     Document Type: Article

References (58)

1. Amalric M, Koob GF (1987). Depletion of dopamine in the caudate nucleus but not the nucleus accumbens impairs reaction-time performance in rats. J Neurosci 7: 2129-2134.
2. Baunez C, Robbins TW (1999). Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience 92: 1343-1356.
3. Beatty WW, Katzung VM, Moreland VJ, Nixon SJ (1995). Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend 37: 247-253.
4. Ben-Shahar O, Ahmed SH, Koob GF, Ettenberg A (2004). The transition from controlled to compulsive drug use is associated with a loss of sensitization. Brain Res 995: 46-54.
5. Berry J, van Gorp W, Herzberg DS, Hinkin C, Boone K, Steinman L et al (1993). Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend 32: 231-237.
6. Bolla KI, Rothman R, Cadet JL (1999). Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsych Clin Neurosci 11: 361-369.
7. Caine SB, Lintz R, Koob GF (1992). Intravenous drug self-administration techniques in animals. In: Sahgal A (ed). Behavioral Neuroscience, a Practical Approach, Volume I. Oxford University Press: Oxford. pp 117-143.
8. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983). Effects of lesions to ascending noradrenergic neurons on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9: 361-380.
9. Chudasama Y, Passetti F, Desai A, Rhodes S, Lopian D, Robbins TW (2003). Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146: 105-119.
10. Cole BJ, Robbins TW (1987). Amphetamine impairs the discriminative performance of rats with dorsal bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic:noradrenergic interactions. Psychopharmacology 91: 458-466.
11. Crider A, Soloman PR, McMahon MA (1982). Disruption of selective attention in the rat following chronic d-amphetamine administration: relationship to schizophrenic attention disorder. Biol Psychiatry 17: 351-361.
12. Dalley JW, McGaughy J, O'Connell MT, Cardinal RN, Levita L, Robbins TW (2001). Distinct changes in cortical acetylcholine and noradrenaline efflux during contingent and non-contingent performance of a visual attentional task. J Neurosci 21: 4908-4914.
13. Dalley JW, Theobald DE, Bouger P, Chudasama Y, Cardinal RN, Robbins TW (2004). Cortical cholinergic fiunction and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex. Cerebral Cortex 14: 922-932.
14. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW (2002). Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 26: 716-728.
15. Deller T, Sarter M (1998). Effects of repeated administration of amphetamine on behavioral vigilance: evidence for sensitized attentional impairments. Psychopharmacology 137: 410-414.
16. Evenden JL (1999). Impulsivity: a discussion of clinical and experimental findings. J Psychopharmacol 13: 180-192.
17. Grant I, Judd LL (1976). Neuropsychological and EEG disturbances in polydrug users. Am J Psychiatry 133: 1039-1042.
18. Himmelheber AM, Sarter M, Bruno JP (2001). The effects of manipulations of attentional demand on cortical acetylcholine release. Cogn Brain Res 12: 353-370.
19. Jentsch JD, Taylor JR (1999). Impulsivity resulting from fronto-striatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146: 373-390.
20. Keppel G (1991). Design and Analysis. Prentice Hall: Englewood Cliffs, NJ.
21. Kondrad RL, Burk JA (2004). Transient disruption of attentional performance following escalating amphetamine administration in rats. Psychopharmacology 175: 436-442.
22. Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A et al (2004). Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27: 739-749.
23. Koob GF, Le Moal M (1997). Drug abuse: hedonic homeostatic dysregulation. Science 278: 52-58.
24. Lehmann O, Grottick AJ, Cassel JC, Higgins GA (2003). A double dissociation between serial reaction time and radial maze performance in rats subjected to 192 IgG-saporin lesions of the nucleus basalis and/or the septal region. Eur J Neurosci 18: 651-666.
25. Levin FR, Kleber HD (1995). Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harvard Rev Psychiatry 2: 246-258.
26. Lin D, Koob GF, Markou A (1999). Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat-interactions between the two drugs. Psychopharmacology 145: 283-294.
27. Mansbach RS, Geyer MA, Braff DL (1988). Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94: 507-514.
28. Markou A, Koob GF (1991). Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4: 17-26.
29. McGaughy J, Dalley JW, Morrison CH, Everitt BJ, Robbins TW (2002). Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task. J Neurosci 22: 1905-1913.
30. McKetin R, Mattick RP (1997). Cognitive changes observed in dependent amphetamine users. Drug Alcohol Depend 48: 235-242.
31. McKetin R, Solowij N (1999). Event-related potential indices of auditory selective attention in dependent amphetamine users. Biol Psychiatry 45: 1488-1497.
32. Muir JL, Robbins TW, Everitt BJ (1996). The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral and parietal cortex lesions on a 5-choice serial reaction time task. Cerebral Cortex 6: 470-481.
33. Nelson CL, Sarter M, Bruno JP (2000). Repeated pretreatment with amphetamine sensitizes increases in cortical acetylcholine release. Psychopharmacology 151: 406-415.
34. O'Malley S, Adamse M, Heaton RK, Gawin FH (1992). Neuropsychological impairments in chronic cocaine abusers. Am J Drug Alcohol Abuse 18: 131-144.
35. Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ et al (2000). Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 23: 113-126.
36. Paine TA, Dringenberg HC, Olmstead MC (2003). Effects of chronic cocaine on impulsivity: relation to cortical serotonin mechanisms. Behav Brain Res 147: 135-147.
37. Parasuraman R, Giambra L (1991). Skill development in vigilance: effects of event rate and age. Psychol Aging 6: 155-169.
38. Ricaurte GA, Seiden LS, Schuster CR (1984). Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res 303: 359-364.
39. Richards JB, Sabol K, de Wit H (1999). Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats. Psychopharmacology 146: 432-439.
40. Risbrough V, Bontempi B, Menzaghi F (2002). Selective immunolesioning of the basal forebrain cholinergic neurons in rats: effect on attention using the 5-choice serial reaction time task. Psychopharmacology 164: 71-81.
41. Robbins TW (2002). The 5-choice serial reaction time task: behavioral pharmacology and functional neurochemistry. Psychopharmacology 163: 363-380.
42. Robbins TW, Sahakian BJ (1983). Behavioral effects of psychomotor stimulant drugs: clinical and neuropsychological implications. In: Creese I (ed). Stimulants: Neurochemical, Behavioral, and Clinical Perspectives. Raven Press: New York, pp 301-338.
43. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive sensitization theory of addiction. Brain Res Rev 18: 247-291.
44. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K et al (1999). Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with frontal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20: 322-339.
45. Rogers RD, Robbins TW (2001). Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 11: 250-257.
46. Rosselli M, Ardila A (1996). Cognitive effects of cocaine and polydrug abuse. J Clin Exp Neuropsychol 18: 122-135.
47. Rossetti ZL, Hmaidan Y, Gessa GL (1992). Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221: 227-234.
48. Sarter M, Bruno JP (1999). Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. TiNS 22: 67-74.
49. Stefanski R, Ladenheim B, Lee S-H, Cadet JL, Goldberg SR (1999). Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol 371: 123-135.
50. Udo T, Ugalde F, DiPietro N, Eichenbaum HB, Kantak KM (2004). Effects of persistent cocaine self-administration on amygdala-dependent and dorsal striatum-dependent learning in rats. Psychopharmacology 174: 237-245.
51. Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schlyer DJ et al (1993). Decreased dopamine D2 receptor availability is associated with reduced frontal metabolisms in cocaine abusers. Synapse 14: 169-177.
52. Volkow ND, Wang G-J, Fowler JS, Logan J, Gatley SJ, Hitzemann R et al (1997). Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830-833.
53. Voytko ML, Olton DS, Richardson RT, German LK, Tobin JR, Price DL (1994). Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 14: 167-186.
54. Weiner I, Lubow RE, Feldon J (1988). Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 30: 871-878.
55. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM et al (1996). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Neurosci 2: 699-703.
56. Winstanley CA, Dalley JW, Theobald DEH, Robbins TW (2004). Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology 29: 1331-1343.
57. Wise RA (1996). Neurobiology of addiction. Curr Opin Neurobiol 6: 243-251.
58. Yokel RA, Pickens R (1974). Drug level of d- and l-amphetamine during intravenous self-administration. Psychopharmacologia 34: 255-264.